By Canadian Press

WHO may reject Canadian-made Medicago COVID-19 vaccine because of ties to big tobacco

Mar 17, 2022 | 8:31 AM

OTTAWA — The World Health Organization says it is expecting to reject the COVID-19 vaccine candidate from Canada’s Medicago because of the company’s ties to big tobacco.

The Medicago Covifenz vaccine was authorized in Canada last month.

Dr. Mariângela Simão, WHO’s assistant director general for drug access, vaccines and pharmaceuticals, says the application for Covifenz to get an emergency-use licence is on hold and will likely be denied because the organization has very strict policies about engaging with tobacco companies.

A spokesman for Medicago says the company has only been told the application is on pause and notes the decision is unrelated to the vaccine’s safety or effectiveness.

Canada has a contract to buy up to 76 million doses of Covifenz but its vaccine strategy is now relying solely on mRNA vaccines from Pfizer-BioNTech and Moderna.

Meaningful Mementos

Remembering Someone You've Lost at Christmas

Dec 03, 2024

Seasonal Sorrow

How Do You Get Through The Holidays When You're Grieving?

Nov 01, 2024

Upcoming Events at Oliver's

Grief & Loss and Estate Planning Seminars

Oct 02, 2024

If the WHO denies the application it would prevent Canada from donating any of its Medicago doses to COVAX.

This report by The Canadian Press was first published March 17, 2022.

The Canadian Press